Get the Weekly Intelligence Brief — top committee picks every Sunday.
NASDAQ · STOCK

Chemed Corp.

CHE Healthcare Unknown Updated July 20, 2026
$501.92
52W $365.21 – $517.74
49/100
27.9
0.52
Explore CHE Further
📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
AI Committee Verdict
Watch
Conviction: Contested · 50% agreement · 6 analysts
+0.8%
-2.8%
0.29:1
Contested
Is CHE Bullish or Bearish?
Mixed. Innellis AI committee rates Chemed Corp. (CHE) Watch with a composite score of 49/100 , based on 6 analysts with 50% agreement. Last updated July 20, 2026.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case — market regime is bullish (bull market -- normal position sizing). Growth Analyst remains cautious — growth rate is decelerating quarter over quarter -- the trend line matters more than the level. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
  • RSI at or above 70 signals overbought conditions — bearish entry bias.
  • Positive MACD histogram signals bullish momentum.
  • Daily trend: uptrend.
  • Daily uptrend conflicts with weekly downtrend — buying against the higher timeframe trend is higher risk.
  • Bullish candlestick pattern(s) detected: Three White Soldiers.
Bear Case
  • RSI is overbought at 83.0 — momentum may be exhausted.
  • Weekly trend is bearish while daily is bullish — against the higher-timeframe trend.
  • Risk/reward is unfavorable: 2.8% downside vs 0.8% upside.
  • Fundamental score is weak (34.8/100) — poor financial health or expensive valuation.
Price History (6M)
AI Investment Committee
Committee Consensus As of July 20, 2026
Overall Committee Score
49/100
Agreement
50%
Analysts
6
Conviction
Contested
Growth Analyst bearish
35 / 100 · Low confidence
Growth story is weak, decelerating, or inconsistent
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst neutral
54 / 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− RSI at 82 is in overbought territory
Risk Analyst bearish
35 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 18.7% signals elevated volatility
Macro Analyst bullish
70 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst neutral
58 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2975.52)
Open Full Terminal →
Investment Thesis Evolution

Committee score weakened from 52.7 to 49.4.

Analyst-level changes:
  • Growth Analyst: score 32->35 (+3).
  • Portfolio Manager: +1 bearish signal(s).
  • Risk Analyst: stance neutral->bearish; score 58->35 (-22).
  • Value Analyst abstained (was neutral at 54).

Comparing 2026-07-19 to 2026-07-20 (1 day apart).

Technical Analysis
RSI (14)
83.0
Overbought
MACD Histogram
2.221
Bullish Momentum
Trend Direction
Uptrend
Weekly: Sideways
Market Structure
Mixed
Support
$499.35
Resistance
$517.73
Bollinger %B
0.90
Inside Bands
Price vs Moving Averages
EMA 9
$497.04 Above
EMA 21
$480.00 Above
EMA 50
$456.57 Above
EMA 200
$445.84 Above
Fundamental Analysis
Valuation
49
Growth
34
Profitability
1
Financial Health
52
Cash Flow
37
Valuation
P/E Ratio 27.9×
P/B Ratio 8.28×
PEG Ratio -2.47
Dividend Yield 0.00%
52W High $517.74
52W Low $365.21
Quality & Growth
ROE 27.1%
ROA 16.2%
Gross Margin 30.3%
Operating Margin 12.9%
Revenue Growth YoY
Debt / Equity 0.28
AI Fundamental Assessment
P/E ratio of 27.9 (moderate relative to a 15-40x range); Price-to-book of 8.3x; PEG ratio of -2.5 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.3%; Return on assets of 0.2%; Net margin of 0.1%; Gross margin of 0.3%; Current ratio of 0.85 (tight short-term liquidity); Debt-to-equity of 0.28; Free cash flow margin of 0.8% (thin cash generation); Free cash flow per share is positive (27.58); Most recent quarter beat estimates by 5.5%; EPS growth decelerating (+21.8% -> -12.0% QoQ); Analyst estimates flat over recent quarters
Key Risks
  • RSI is overbought at 83.0 — momentum may be exhausted.
  • Weekly trend is bearish while daily is bullish — against the higher-timeframe trend.
  • Risk/reward is unfavorable: 2.8% downside vs 0.8% upside.
  • Fundamental score is weak (34.8/100) — poor financial health or expensive valuation.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full CHE Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal → Mobile
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime